Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis
William W. Busse, Sally E. Wenzel, Thomas B. Casale, J. Mark FitzGerald, Megan S. Rice, Nadia Daizadeh, Yamo Deniz, Naimish Patel, Sivan Harel, Paul J. Rowe, Neil M.H. Graham, Thomas G. O’Riordan, Ian Pavord
Topics & Concepts
MedicineAsthmaExhaled nitric oxidePost-hoc analysisExacerbationBiomarkerInternal medicinePlaceboEosinophilPopulationImmunologySpirometryPathologyChemistryAlternative medicineEnvironmental healthBiochemistryAsthma and respiratory diseasesDelphi Technique in ResearchNitric Oxide and Endothelin Effects